IL133511A - A method of preparing citalopram and pharmaceutical mixtures containing it - Google Patents

A method of preparing citalopram and pharmaceutical mixtures containing it

Info

Publication number
IL133511A
IL133511A IL13351198A IL13351198A IL133511A IL 133511 A IL133511 A IL 133511A IL 13351198 A IL13351198 A IL 13351198A IL 13351198 A IL13351198 A IL 13351198A IL 133511 A IL133511 A IL 133511A
Authority
IL
Israel
Prior art keywords
formula
compound
acid
reaction
citalopram
Prior art date
Application number
IL13351198A
Other languages
English (en)
Hebrew (he)
Other versions
IL133511A0 (en
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority to IL15312598A priority Critical patent/IL153125A0/xx
Publication of IL133511A0 publication Critical patent/IL133511A0/xx
Publication of IL133511A publication Critical patent/IL133511A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
IL13351198A 1997-07-08 1998-03-03 A method of preparing citalopram and pharmaceutical mixtures containing it IL133511A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL15312598A IL153125A0 (en) 1997-07-08 1998-03-03 Method for the preparation of citalopram

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5278897P 1997-07-08 1997-07-08
DK82697 1997-07-08
PCT/DK1998/000081 WO1998019513A2 (en) 1997-07-08 1998-03-03 Method for the preparation of citalopram

Publications (2)

Publication Number Publication Date
IL133511A0 IL133511A0 (en) 2001-04-30
IL133511A true IL133511A (en) 2004-05-12

Family

ID=26064729

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13351198A IL133511A (en) 1997-07-08 1998-03-03 A method of preparing citalopram and pharmaceutical mixtures containing it
IL153125A IL153125A (en) 1997-07-08 2002-11-27 Intermediate compounds for the preparation of citalopram

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL153125A IL153125A (en) 1997-07-08 2002-11-27 Intermediate compounds for the preparation of citalopram

Country Status (23)

Country Link
US (1) US6229026B1 (is)
EP (1) EP1015416B1 (is)
JP (1) JP3526581B2 (is)
KR (1) KR100357975B1 (is)
CN (1) CN1206207C (is)
AT (1) ATE205824T1 (is)
AU (1) AU737610B2 (is)
BG (1) BG64823B1 (is)
CA (1) CA2291067C (is)
CZ (1) CZ291440B6 (is)
DE (2) DE69801764T2 (is)
DK (1) DK1015416T3 (is)
EA (1) EA001728B1 (is)
ES (1) ES2148120T3 (is)
HU (1) HU228744B1 (is)
IL (2) IL133511A (is)
IS (1) IS2023B (is)
NO (1) NO322146B1 (is)
NZ (1) NZ501737A (is)
PT (1) PT1015416E (is)
SK (1) SK283309B6 (is)
TR (1) TR200000066T2 (is)
WO (1) WO1998019513A2 (is)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
KR100411505B1 (ko) * 1998-10-20 2003-12-18 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조방법
CA2356188C (en) * 1998-12-23 2006-05-23 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) * 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
ATE237604T1 (de) * 1999-04-14 2003-05-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
US6245782B1 (en) 1999-05-17 2001-06-12 Heartdrug Research L.L.C. Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991486A1 (it) * 1999-07-06 2001-01-06 Vis Farmaceutici S P A Processo per la sintesi di citalopram
ES2229774T3 (es) 1999-10-25 2005-04-16 H. Lundbeck A/S Metodo para la preparacion de citalopram.
DE69920526T2 (de) 1999-10-25 2006-02-23 H. Lundbeck A/S Verfahren zur herstellung von citalopram
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
SI1246812T1 (en) 1999-12-28 2004-08-31 H. Lundbeck A/S Method for the preparation of citalopram
HUP0203840A3 (en) * 1999-12-30 2005-02-28 Lundbeck & Co As H Method for the preparation of citalopram
IL150561A0 (en) 2000-01-14 2003-02-12 Lundbeck & Co As H Method for the preparation of 5-cyanophthalide
IT1317729B1 (it) * 2000-01-18 2003-07-15 Norpharma S P A Procedimento per la preparazione della 5-carbossiftalide.
NL1017415C1 (nl) 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
CA2402553A1 (en) 2000-03-13 2001-09-20 H. Lundbeck A/S Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
CN1429219A (zh) 2000-03-13 2003-07-09 H·隆德贝克有限公司 制备西酞普兰的方法
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
ATE257832T1 (de) 2000-03-14 2004-01-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
TR200202168T2 (tr) * 2000-03-16 2002-12-23 H. Lundbeck A/S 5-Siyano-1-(4-Florofenil)-1,3-Dihidroizobenzofuranların preparasyon metodu
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
FI20011621A (fi) * 2000-08-18 2002-02-19 Lundbeck & Co As H Menetelmä sitalopraamin valmistamiseksi
IT1319686B1 (it) * 2000-12-12 2003-10-23 C D Farmasint S R L Procedimento di preparazione di citalopram.
EA003581B1 (ru) * 2000-12-22 2003-06-26 Х.Лундбекк А/С Способ получения чистого циталопрама
DE10112828C1 (de) * 2000-12-28 2002-11-21 Lundbeck & Co As H Verfahren zur Herstellung von Citalopram
EA003459B1 (ru) * 2000-12-28 2003-06-26 Х.Лундбекк А/С Способ получения чистого циталопрама
CA2435925A1 (en) 2001-01-30 2002-08-08 Orion Corporation Fermion Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
BG65271B1 (bg) * 2001-06-18 2007-11-30 H. Lundbeck A/S Метод за получаване на циталопрам
IN192057B (is) * 2001-07-19 2004-02-14 Ranbaxy Lab Ltd
EA006213B1 (ru) 2001-07-31 2005-10-27 Х. Лундбекк А/С Кристаллическая композиция, содержащая эсциталопрам
PT1281707E (pt) * 2001-08-02 2005-04-29 Infosint Sa Processo para a preparacao de isobenzofuranos 5-substituidos
GR1004635B (el) * 2001-08-14 2004-07-14 H@Αlundbeckαa@Sαα Μεθοδοσαπαρασκευησατησασιταλοπραμης@αα
EP1288211A1 (en) * 2001-08-28 2003-03-05 Sekhsaria Chemicals Ltd. Improved process for the manufacture of citalopram hydrobromide from 5-bromophthalide
US7148364B2 (en) 2002-01-07 2006-12-12 Sun Pharmaceutical Industries Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile
GB2387596B (en) * 2002-02-27 2004-02-11 Matrix Lab Ltd Process
HU0200980D0 (is) * 2002-03-14 2002-05-29 Gabor S Pal Dr
BG65515B1 (bg) * 2002-07-26 2008-10-31 H. Lundbeck A/S Метод за получаване на 5-цианофталид
WO2004016602A1 (en) * 2002-08-14 2004-02-26 Natco Pharma Limited Process for the preparation of high purity citalopram and its pharmaceutically acceptable salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
ITMI20030479A1 (it) * 2003-03-13 2004-09-14 Adorkem Technology S P A Procedimento per la preparazione di un ciano-isobenzofurano.
EP1611118A2 (en) 2003-03-21 2006-01-04 H. Lundbeck A/S Intermediates for the preparation of citalopram and escitalopram
EP1486492A3 (en) 2003-06-10 2005-02-23 Sun Pharmaceuticals Industries Ltd. A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
EP1506963B1 (en) * 2003-10-28 2005-04-13 Adorkem Technology SpA Method for the preparation of citalopram
WO2006021971A2 (en) 2004-08-23 2006-03-02 Sun Pharmaceutical Industries Limited 'process for preparation of citalopram and enantiomers'
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US9339500B2 (en) * 2008-03-04 2016-05-17 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (is) 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
DK213290D0 (da) * 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
NZ243065A (en) 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
WO1998019513A3 (en) 2000-05-04
HU228744B1 (en) 2013-05-28
ATE205824T1 (de) 2001-10-15
CA2291067A1 (en) 1998-05-14
EP1015416A2 (en) 2000-07-05
EA200000102A1 (ru) 2000-06-26
IL133511A0 (en) 2001-04-30
SK32000A3 (en) 2000-07-11
KR20010021516A (ko) 2001-03-15
DK1015416T3 (da) 2001-11-05
US6229026B1 (en) 2001-05-08
EA001728B1 (ru) 2001-08-27
HUP0003177A3 (en) 2002-12-28
NZ501737A (en) 2001-10-26
CZ200062A3 (cs) 2000-07-12
AU6609898A (en) 1998-05-29
ES2148120T3 (es) 2002-01-16
HUP0003177A2 (hu) 2001-04-28
CN1206207C (zh) 2005-06-15
KR100357975B1 (ko) 2002-10-25
DE69801764T2 (de) 2002-07-04
AU737610B2 (en) 2001-08-23
IL153125A (en) 2008-11-03
TR200000066T2 (tr) 2000-11-21
CA2291067C (en) 2002-07-30
BG64823B1 (bg) 2006-05-31
EP1015416B1 (en) 2001-09-19
NO322146B1 (no) 2006-08-21
DE69801764D1 (de) 2001-10-25
JP2002509526A (ja) 2002-03-26
ES2148120T1 (es) 2000-10-16
DE1015416T1 (de) 2000-10-05
BG104116A (en) 2000-12-29
JP3526581B2 (ja) 2004-05-17
WO1998019513A2 (en) 1998-05-14
IS5300A (is) 1999-12-14
IS2023B (is) 2005-08-15
CN1495157A (zh) 2004-05-12
CZ291440B6 (cs) 2003-03-12
NO20000008L (no) 2000-01-03
PT1015416E (pt) 2002-03-28
SK283309B6 (sk) 2003-05-02
NO20000008D0 (no) 2000-01-03

Similar Documents

Publication Publication Date Title
EP1015416B1 (en) Method for the preparation of citalopram
EP1032566B1 (en) Method for the preparation of citalopram
EP1042310B1 (en) Method for the preparation of citalopram
EP1173431B2 (en) Method for the preparation of citalopram
US6566540B2 (en) Method for the preparation of citalopram or S-citalopram
KR100511532B1 (ko) 시탈로프람의 제조방법
MXPA99011854A (en) Method for the preparation of citalopram
BG64446B1 (en) Method for the preparation of citalopram, intermediates for its materialization and antidepressive agent
ZA200107956B (en) Method for the preparation of citalopram.
NZ504069A (en) Preparing 4-dimethylamino-1-(4-amino-2-hydroxymethylphenyl)-1-(4-fluorophenyl)butan-1-ol or 4-dimethylamino-1-(4-acetylamino-2-hydroxymethylphenyl)-1-(4-fluorophenyl)butan-1-ol using Grignard reagent 4-halogen-fluorophenyl
BG64901B1 (bg) Метод за получаване на циталопрам

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees